Showing results (331-340 of 358) with videos related to

Sort By:
Pageof 36
Cancers|November 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNAKaren Aughton, Nils O Elander, Anthony Evans, et al.
Surgery|May 27, 2014
Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)Werner Hartwig, Charles M Vollmer, Abe Fingerhut, et al.
JAMA|July 12, 2012
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trialJohn P Neoptolemos, Malcolm J Moore, Trevor F Cox, et al.
The Astrophysical Journal. Letters|October 17, 2025
Discovery of the Seven-ring Polycyclic Aromatic Hydrocarbon Cyanocoronene (C24H11CN) in GOTHAM Observations of TMC-1Gabi Wenzel, Siyuan Gong, Ci Xue, et al.
Surgery|July 26, 2014
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)Johanna A M G Tol, Dirk J Gouma, Claudio Bassi, et al.
Open Research Europe|August 5, 2024
Atacama Large Aperture Submillimeter Telescope (AtLAST) Science: Planetary and Cometary AtmospheresMartin Cordiner, Alexander Thelen, Thibault Cavalie, et al.
Environment International|March 13, 2016
China's soil and groundwater management challenges: Lessons from the UK's experience and opportunities for ChinaFrédéric Coulon, Kevin Jones, Hong Li, et al.
Gut|December 3, 2009
The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis familiesChristopher J Grocock, Vinciane Rebours, Myriam N Delhaye, et al.
The Lancet Regional Health. Europe|April 18, 2025
Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmissionGina E C Charnley, Tilly Alcayna, Alex Almuedo-Riera, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase InhibitorsCurt D Haffner, Adam K Charnley, Christopher J Aquino, et al.
Pageof 36